Costs and Cost Drivers of Providing Option B+ Services to Mother-Baby Pairs for PMTCT of HIV in Health Centre IV Facilities in Jinja District, Uganda

Background. In 2013, the World Health Organization (WHO) revised the 2012 guidelines on use of antiretroviral drugs (ARVs) for the prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV). The new guidelines recommended lifelong antiretroviral therapy (ART) for all HI...

Full description

Bibliographic Details
Main Authors: Aggrey D. Mukose, Senait Kebede, Christine Muhumuza, Fredrick Makumbi, Henry Komakech, Esther Bayiga, Denis Busobozi, Joshua Musinguzi, Andreas Kuznik, Peter Stegman, Steven Forsythe, Joseph Kagaayi
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/2875864

Similar Items